Flumazenil 5 Ml B. Braun And Flumazenil 10 Ml B. Braun 0,5 mg/5 ml AND 1 mg/10 ml Solution for injection
PDF Leaflet Revision Date: 10 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Reversal of benzodiazepine sedation.
Dosage (summary)
Initial dose: 0.2 mg IV over 15 seconds; max total: 1 mg.
Onset of Action / Duration
Onset: 1-2 mins, Duration: variable.
Special Populations
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety not established; discontinue breastfeeding for 24 hours post-treatment.
Key Drug Interactions
- Benzodiazepines
- Cyclic antidepressants
Contraindications
- Hypersensitivity to flumazenil
- Life-threatening conditions managed with benzodiazepines
Common side effects
- Insomnia
- Somnolence
- Nausea
- Headache
- Fatigue
Counselling Points
- Avoid driving for 24 hours
- Monitor for withdrawal symptoms
- Administer slowly to avoid adverse effects
Serious warnings
- Risk of resedation
- Monitor for seizures in epilepsy patients
Important Disclaimer
The Flumazenil 5 Ml B. Braun And Flumazenil 10 Ml B. Braun 0,5 mg/5 ml AND 1 mg/10 ml Solution for injection professional information leaflet below is the property of B Braun Medical and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
